#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15014	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2128	685.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1444	1444	C	968	C	873	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15014	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2128	685.2	0	HET	.	.	.	C326T,A	.	326	326	C	586	586	C	672	C,T,A	474,160,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15014	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2128	685.2	0	HET	.	.	.	C207T	.	207	207	C	467	467	C	700	C,T	502,122	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27818	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3516	770.3	0	.	n	.	0	T695C	SNP	695	695	T	1068	1068	C	1072	C	1001	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27818	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3516	770.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	2011	2011	G	702	G	643	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27818	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3516	770.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2344	2344	C	860	C	774	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27818	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3516	770.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2418	2418	A	923	A	829	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27818	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3516	770.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2970	2970	C	835	C	749	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	960	folP	855	855	100.0	folP.l15.c4.ctg.1	1761	52.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1161	1163	AGC	96;98;101	A;G;C	84;86;88	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2766	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3447	77.3	1	SNP	p	S91F	1	.	.	271	273	TTC	583	585	TTC	105;107;107	T;T;C	95;97;96	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2766	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3447	77.3	1	SNP	p	G95N	0	.	.	283	285	GGC	595	597	GGC	112;112;109	G;G;C	103;103;102	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2766	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3447	77.3	1	SNP	p	D95G	1	.	.	283	285	GGC	595	597	GGC	112;112;109	G;G;C	103;103;102	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	814	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1329	59.1	1	SNP	p	G45D	0	.	.	133	135	GGC	472	474	GGC	107;108;106	G;G;C	95;95;94	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	512	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	954	51.7	0	.	n	.	0	A197.	DEL	197	197	A	535	535	A	114	A	109	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2356	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2897	78.2	1	SNP	p	D86N	0	.	.	256	258	GAC	421	423	GAC	100;100;103	G;A;C	96;94;99	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2356	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2897	78.2	1	SNP	p	R87I	0	.	.	259	261	CGT	424	426	CGT	103;103;103	C;G;T	100;99;99	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2356	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2897	78.2	1	SNP	p	R87W	0	.	.	259	261	CGT	424	426	CGT	103;103;103	C;G;T	100;99;99	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2356	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2897	78.2	1	SNP	p	S87R	1	.	.	259	261	CGT	424	426	CGT	103;103;103	C;G;T	100;99;99	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2356	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2897	78.2	1	SNP	p	S88P	0	.	.	262	264	TCC	427	429	TCC	103;105;105	T;C;C	99;102;102	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2086	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2923	68.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1728	1730	GGC	59;60;59	G;G;C	58;59;57	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2472	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2423	99.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1314	1316	GCC	176;176;173	G;C;C	153;151;149	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2472	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2423	99.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1317	1319	ATG	162;157;158	A;T;G	143;141;141	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2472	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2423	99.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1329	1331	ACC	175;175;170	A;C,A;C	155;158,1;155	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2472	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2423	99.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1329	1331	ACC	175;175;170	A;C,A;C	155;158,1;155	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2472	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2423	99.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1830	1832	ACC	112;112;112	A;C;C	105;104;105	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2472	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2423	99.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1884	1886	GCG	90;89;90	G;C;G	87;85;86	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2472	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2423	99.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1884	1886	GCG	90;89;90	G;C;G	87;85;86	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2472	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2423	99.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2007	2009	GGT	64;62;58	G;G;T	63;61;58	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2472	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2423	99.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2016	2018	AGC	50;50;50	A;G;C	49;50;50	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2472	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2423	99.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2034	2036	CCG	24;20;20	C;C;G	24;20;20	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	263	4446	ponA	2397	2338	100.0	ponA.l6.c4.ctg.1	2611	153.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1534	1536	CCG	69;69;71	C;C;G	67;66;65	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	263	4446	ponA	2397	149	100.0	ponA.l6.c4.ctg.2	667	36.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1018	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1742	56.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	585	585	C	50	C	45	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	118	porB1a	984	308	90.38	porB1a.l6.c30.ctg.2	344	15.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	61	63	AAT	5;8;8	A;A;T	4;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	118	porB1a	984	308	90.38	porB1a.l6.c30.ctg.2	344	15.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	64	66	AAT	8;8;8	A;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	118	porB1a	984	308	90.38	porB1a.l6.c30.ctg.2	344	15.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	88	90	GCA	8;8;9	G;C;A	7;8;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	118	porB1a	984	308	90.38	porB1a.l6.c30.ctg.2	344	15.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	111	113	GTA	10;10;10	G;T;A	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	118	porB1a	984	308	90.38	porB1a.l6.c30.ctg.2	344	15.2	0	.	p	.	0	W235trunc	TRUNC	703	703	T	114	114	T	10	T	10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	118	porB1a	984	308	90.38	porB1a.l6.c30.ctg.2	344	15.2	0	.	p	.	0	N237fs	FSHIFT	709	709	A	120	120	A	10	A	10	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1824	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1879	94.6	0	.	p	.	0	E209K	NONSYN	625	627	GAA	1021	1023	AAA	199;202;203	A;A;A	183;186;187	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1824	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1879	94.6	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1150	1152	GAA	165;165;164	G;A;A	156;156;155	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1824	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1879	94.6	1	SNP	p	G120K	1	.	.	358	360	AAG	754	756	AAG	128;129;134	A;A;G	118;119;123	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1824	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1879	94.6	1	SNP	p	N121D	0	.	.	361	363	AAC	757	759	AAC	134;131;137	A;A;C	123;120;124	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1824	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1879	94.6	1	SNP	p	A121N	1	.	.	361	363	AAC	757	759	AAC	134;131;137	A;A;C	123;120;124	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6616	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4858	132.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	580	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1087	52.2	1	SNP	p	V57M	1	.	.	169	171	ATG	530	532	ATG	114;112;113	A;T;G	101;97;99	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
